These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. van 't Hof AW; Ernst N; de Boer MJ; de Winter R; Boersma E; Bunt T; Petronio S; Marcel Gosselink AT; Jap W; Hollak F; Hoorntje JC; Suryapranata H; Dambrink JH; Zijlstra F; Eur Heart J; 2004 May; 25(10):837-46. PubMed ID: 15140531 [TBL] [Abstract][Full Text] [Related]
8. Effect of adjunctive tirofiban therapy on angiographic and clinical outcomes in patients with ST-segment elevated acute myocardial infarction undergoing primary stenting. Yeh KH; Chen MC; Chang HW; Yu TH; Chen CJ; Chen YH; Chai HT; Wang CP; Hang CL; Fu M; Wu CJ; Yip HK Jpn Heart J; 2004 Jan; 45(1):31-41. PubMed ID: 14973348 [TBL] [Abstract][Full Text] [Related]
9. Safety and feasibility of a novel dosing regimen of tirofiban administered in patients with acute myocardial infarction with ST elevation before primary coronary angioplasty: a pilot study. Kochman W; Dobrzycki S; Nowak KS; Chlopicki S; Kralisz P; Prokopczuk P; Bachorzewska-Gajewska H; Gugala K; Niewada M; Mezynski G; Poniatowski B; Korecki J; Musial WJ J Thromb Thrombolysis; 2004 Apr; 17(2):127-31. PubMed ID: 15306748 [TBL] [Abstract][Full Text] [Related]
10. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes. Yip HK; Wu CJ; Chang HW; Hsieh YK; Fang CY; Chen SM; Chen MC Chest; 2003 Sep; 124(3):962-8. PubMed ID: 12970024 [TBL] [Abstract][Full Text] [Related]
11. Early abciximab administration in acute myocardial infarction treated with primary coronary intervention. Bellandi F; Maioli M; Leoncini M; Toso A; Dabizzi RP Int J Cardiol; 2006 Mar; 108(1):36-42. PubMed ID: 15927285 [TBL] [Abstract][Full Text] [Related]
12. Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial. Lee DP; Herity NA; Hiatt BL; Fearon WF; Rezaee M; Carter AJ; Huston M; Schreiber D; DiBattiste PM; Yeung AC; Circulation; 2003 Mar; 107(11):1497-501. PubMed ID: 12654606 [TBL] [Abstract][Full Text] [Related]
13. Effects of tirofiban maintenance duration on myocardial perfusion defect severity in anterior myocardial infarction. Tas MH; Simsek Z; Ayan A; Aksu U; Demirelli S; Koza Y; Lazoglu Z; Seven B; Senocak H Adv Ther; 2013 Sep; 30(9):834-44. PubMed ID: 24057341 [TBL] [Abstract][Full Text] [Related]
14. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. Kastrati A; Mehilli J; Schlotterbeck K; Dotzer F; Dirschinger J; Schmitt C; Nekolla SG; Seyfarth M; Martinoff S; Markwardt C; Clermont G; Gerbig HW; Leiss J; Schwaiger M; Schömig A; JAMA; 2004 Feb; 291(8):947-54. PubMed ID: 14982910 [TBL] [Abstract][Full Text] [Related]
15. [Effect of pre-angiography use of tirofiban in patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention]. Xu L; Yang XC; Wang LF; Ge YG; Wang HS; Li WM; Ni ZH; Liu Y; Cui L Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Nov; 34(11):983-6. PubMed ID: 17288757 [TBL] [Abstract][Full Text] [Related]
16. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. Schömig A; Kastrati A; Dirschinger J; Mehilli J; Schricke U; Pache J; Martinoff S; Neumann FJ; Schwaiger M N Engl J Med; 2000 Aug; 343(6):385-91. PubMed ID: 10933737 [TBL] [Abstract][Full Text] [Related]
17. Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. Valgimigli M; Tebaldi M; Campo G; Gambetti S; Bristot L; Monti M; Parrinello G; Ferrari R; JACC Cardiovasc Interv; 2012 Mar; 5(3):268-77. PubMed ID: 22440491 [TBL] [Abstract][Full Text] [Related]
18. [Pilot study of the effectiveness of combination therapy with reduced dose alteplase and the glycoprotein IIb/IIIa antagonist tirofiban in acute myocardial infarct]. Peters S; Trümmel M; Brattström A; Meyners W Z Kardiol; 2002 Mar; 91(3):233-7. PubMed ID: 12001538 [TBL] [Abstract][Full Text] [Related]
19. Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kırma C; Erkol A; Pala S; Oduncu V; Dündar C; İzgi A; Tigen K; Gibson CM Catheter Cardiovasc Interv; 2012 Jan; 79(1):59-67. PubMed ID: 21523892 [TBL] [Abstract][Full Text] [Related]
20. Thrombus aspiration plus intra-infarct-related artery administration of tirofiban improves myocardial perfusion during primary angioplasty for acute myocardial infarction. Yan HB; Li SY; Song L; Wang J; Wu Z; Chi YP; Zheng B; Zhao HJ; Li QX; Zhang XJ; Li WZ Chin Med J (Engl); 2010 Apr; 123(7):877-83. PubMed ID: 20497681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]